Results 111 to 120 of about 1,758,994 (174)

Chemogenetic inhibition of Grpr- and/or Npff-expressing spinal neurons in mice suppresses chloroquine-evoked itch but not signs of mechanical allodynia in a neuropathic pain model. [PDF]

Pain
Polgár E, Gutierrez-Mecinas M, Dickie AC, Abu Hajer M, Cooper AH, Weir GA, Todd AJ.   +6 more
europepmc   +1 more source

The contribution of endocytic mediators to itch transmission. [PDF]

Front Mol Neurosci
Ferreira MA, Tonello R, Duran P, Trevett K, Jensen DD.   +4 more
europepmc   +1 more source

Radionuclide-based pharmaceuticals for breast cancer imaging: state of the art. [PDF]

EJNMMI Radiopharm Chem
Paraïso P, van Deurzen CHM, Seimbille Y.   +2 more
europepmc   +1 more source

Future of radiotheranostics. [PDF]

BMJ Oncol
Al-Ibraheem A, Moghrabi S, Al-Houwari RM, Al-Qasem S, Abdulrahman M, Alzorgan N, Sohil Al-Qatawna L, Al-Hammouri Q, Ghanameh M, Ruzzeh S, Abdlkadir AS.   +10 more
europepmc   +1 more source

Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results. [PDF]

J Nucl Med
Mittra ES, Solnes LB, van der Veldt AAM, Wong J, Aloj L, Heinrich MC, Chen CT, Rowe SP, Brabander T, Pacey S, Aimone P, Pathak D, Blumenstein L, Liu Y, Iagaru A.   +14 more
europepmc   +1 more source

Biodistribution of the Bombesin Receptor-Targeted Radiopharmaceutical Precursor BBN/C1-C2 in a Prostate Cancer Model. [PDF]

Sovrem Tekhnologii Med
Beloborodov EA, Iurova EV, Dolgova DR, Ermakova AA, Sugak DE, Fomin AN, Saenko YV.   +6 more
europepmc   +1 more source

Gastrin-Releasing Peptide Receptors Stimulate MAPK-Mediated Growth of Lung Cancer Cells by Transactivating HER4 in a Neuregulin-1, MAP Kinase-Dependent Manner Requiring Activation of the ROS-System. [PDF]

Biology (Basel)
Moody TW, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT.   +4 more
europepmc   +1 more source

The next evolution of theranostics: from target discovery to integrated precision medicine. [PDF]

Front Med (Lausanne)
Montemagno C, Serrano B, Paulmier B.
europepmc   +1 more source

In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications. [PDF]

EJNMMI Res
Hulse DGE, Harper I, Tan F, Gillett D, Warnes V, McLean M, Wodtke P, Gallagher F, Maher ER, Giger O, Bulusu R, Aloj L, Casey RT.   +12 more
europepmc   +1 more source

Preclinical Evaluation of a ¹⁷⁷Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus. [PDF]

ACS Pharmacol Transl Sci
Kumar N, Bilinska A, Menéndez E, Läppchen T, Kanellopoulos P, Orlova A, Rösch F, Rominger A, Gourni E.   +8 more
europepmc   +1 more source